These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38499180)

  • 21. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
    Gong L; Bao L; Tian T; Li Y
    J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-Label Use of Topical Minoxidil in Alopecia: A Review.
    Stoehr JR; Choi JN; Colavincenzo M; Vanderweil S
    Am J Clin Dermatol; 2019 Apr; 20(2):237-250. PubMed ID: 30604379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Minoxidil: more than an antihypertensive].
    Bierl H
    Hautarzt; 2001 Jan; 52(1):p following 90 (91-2). PubMed ID: 11220249
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls.
    Olamiju B; Craiglow BG
    J Am Acad Dermatol; 2021 Jun; 84(6):1689-1691. PubMed ID: 33333154
    [No Abstract]   [Full Text] [Related]  

  • 25. Minoxidil in the treatment of androgenetic alopecia.
    Goren A; Naccarato T
    Dermatol Ther; 2018 Sep; 31(5):e12686. PubMed ID: 30155952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness.
    Choi JW; Na SY; Park KC; Youn SW; Huh CH
    J Am Acad Dermatol; 2012 Jan; 66(1):e10-2. PubMed ID: 22177646
    [No Abstract]   [Full Text] [Related]  

  • 27. The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia.
    Maqoud F; Zizzo N; Mele A; Denora N; Passantino G; Scala R; Cutrignelli A; Tinelli A; Laquintana V; la Forgia F; Fontana S; Franco M; Lopedota AA; Tricarico D
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00585. PubMed ID: 32378360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
    Sanabria B; Vanzela TN; Miot HA; Müller Ramos P
    J Am Acad Dermatol; 2021 Apr; 84(4):1175-1178. PubMed ID: 33253848
    [No Abstract]   [Full Text] [Related]  

  • 31. Three percent topical minoxidil therapy for female androgenetic alopecia.
    Hordinsky MK; Shank J
    Clin Dermatol; 1988; 6(4):213-7. PubMed ID: 3214822
    [No Abstract]   [Full Text] [Related]  

  • 32. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
    Sinclair RD
    Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia.
    Thuangtong R; Thanomkitti K; Suvanasuthi S
    J Med Assoc Thai; 2017 Jan; 100(1):70-7. PubMed ID: 29911772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hair loss.
    Patel JC
    Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
    [No Abstract]   [Full Text] [Related]  

  • 35. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series.
    Beach RA; McDonald KA; Muylaert Barrett B
    J Am Acad Dermatol; 2021 Mar; 84(3):761-763. PubMed ID: 33098962
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases.
    Tosti A
    Dermatologica; 1986; 173(3):136-8. PubMed ID: 3770260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.